In8bio, Inc.INAB
Price (close)
$1.19
Market cap
$11.7M
P/E
—
Revenue (TTM)
—
Net income
-$18.7M
Dividend yield
—
1-year total return
-43.1%
Net margin
—
Revenue growth
—
Debt / equity
—
What In8bio, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net income | -$8.6M | -$14.7M | -$28.5M | -$30.0M | -$30.4M | -$19.4M |
More on INAB.
- In8bio, Inc. summary
- In8bio, Inc. financial statements
- In8bio, Inc. key metrics
- In8bio, Inc. health scores and style box
- In8bio, Inc. earnings
- In8bio, Inc. dividends
- In8bio, Inc. valuation
- In8bio, Inc. ownership and insiders
- In8bio, Inc. peers
Figures from In8bio, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.